UBS Group’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.8K | Sell |
16,320
-5,450
| -25% | -$3.95K | ﹤0.01% | 7449 |
|
|
2025
Q1 | $18.7K | Sell |
21,770
-25,460
| -54% | -$21.9K | ﹤0.01% | 6975 |
|
|
2024
Q4 | $79.3K | Buy |
47,230
+19,449
| +70% | +$32.7K | ﹤0.01% | 5796 |
|
|
2024
Q3 | $79.2K | Buy |
27,781
+7,628
| +38% | +$21.7K | ﹤0.01% | 5326 |
|
|
2024
Q2 | $47.2K | Sell |
20,153
-31,434
| -61% | -$73.6K | ﹤0.01% | 5588 |
|
|
2024
Q1 | $152K | Sell |
51,587
-5,143
| -9% | -$15.1K | ﹤0.01% | 4878 |
|
|
2023
Q4 | $170K | Buy |
56,730
+28,999
| +105% | +$86.7K | ﹤0.01% | 4693 |
|
|
2023
Q3 | $87.6K | Sell |
27,731
-2,833
| -9% | -$8.95K | ﹤0.01% | 4799 |
|
|
2023
Q2 | $118K | Buy |
30,564
+13,251
| +77% | +$51.3K | ﹤0.01% | 4824 |
|
|
2023
Q1 | $48K | Buy |
17,313
+2,864
| +20% | +$7.93K | ﹤0.01% | 5410 |
|
|
2022
Q4 | $26K | Buy |
+14,449
| New | +$26K | ﹤0.01% | 6214 |
|
|
2022
Q2 | – | Sell |
-804
| Closed | -$3K | – | 9545 |
|
|
2022
Q1 | $3K | Sell |
804
-4,827
| -86% | -$18K | ﹤0.01% | 8405 |
|
|
2021
Q4 | $30K | Sell |
5,631
-31,682
| -85% | -$169K | ﹤0.01% | 6294 |
|
|
2021
Q3 | $229K | Buy |
+37,313
| New | +$229K | ﹤0.01% | 4180 |
|
|
2020
Q4 | – | Sell |
-147
| Closed | -$2K | – | 7525 |
|
|
2020
Q3 | $2K | Buy |
+147
| New | +$2K | ﹤0.01% | 6790 |
|